Studying the antibody repertoire after vaccination: Practical applications

Nearly all licensed vaccines have been developed to confer protection against infectious diseases by stimulating the production of antibodies by B cells, but the nature of a successful antibody response has been difficult to capture. Recent advances in next-generation sequencing (NGS) technology hav...

Full description

Bibliographic Details
Main Authors: Galson, J, Pollard, A, Trück, J, Kelly, D
Format: Journal article
Language:English
Published: Elsevier 2014
_version_ 1797086804057260032
author Galson, J
Pollard, A
Trück, J
Kelly, D
author_facet Galson, J
Pollard, A
Trück, J
Kelly, D
author_sort Galson, J
collection OXFORD
description Nearly all licensed vaccines have been developed to confer protection against infectious diseases by stimulating the production of antibodies by B cells, but the nature of a successful antibody response has been difficult to capture. Recent advances in next-generation sequencing (NGS) technology have allowed high-resolution characterization of the antibody repertoire, and of the changes that occur following vaccination. These approaches have yielded important insights into the B cell response, and have raised the possibility of using specific antibody sequences as measures of vaccine immunogenicity. Here, we review recent findings based on antibody repertoire sequencing, and discuss potential applications of these new technologies and of the analyses of the increasing volume of antibody sequence data in the context of vaccine development. © 2014 Elsevier Ltd.
first_indexed 2024-03-07T02:27:10Z
format Journal article
id oxford-uuid:a60241ba-c9dd-4b97-af03-790541d72cbe
institution University of Oxford
language English
last_indexed 2024-03-07T02:27:10Z
publishDate 2014
publisher Elsevier
record_format dspace
spelling oxford-uuid:a60241ba-c9dd-4b97-af03-790541d72cbe2022-03-27T02:44:17ZStudying the antibody repertoire after vaccination: Practical applicationsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a60241ba-c9dd-4b97-af03-790541d72cbeEnglishSymplectic Elements at OxfordElsevier2014Galson, JPollard, ATrück, JKelly, DNearly all licensed vaccines have been developed to confer protection against infectious diseases by stimulating the production of antibodies by B cells, but the nature of a successful antibody response has been difficult to capture. Recent advances in next-generation sequencing (NGS) technology have allowed high-resolution characterization of the antibody repertoire, and of the changes that occur following vaccination. These approaches have yielded important insights into the B cell response, and have raised the possibility of using specific antibody sequences as measures of vaccine immunogenicity. Here, we review recent findings based on antibody repertoire sequencing, and discuss potential applications of these new technologies and of the analyses of the increasing volume of antibody sequence data in the context of vaccine development. © 2014 Elsevier Ltd.
spellingShingle Galson, J
Pollard, A
Trück, J
Kelly, D
Studying the antibody repertoire after vaccination: Practical applications
title Studying the antibody repertoire after vaccination: Practical applications
title_full Studying the antibody repertoire after vaccination: Practical applications
title_fullStr Studying the antibody repertoire after vaccination: Practical applications
title_full_unstemmed Studying the antibody repertoire after vaccination: Practical applications
title_short Studying the antibody repertoire after vaccination: Practical applications
title_sort studying the antibody repertoire after vaccination practical applications
work_keys_str_mv AT galsonj studyingtheantibodyrepertoireaftervaccinationpracticalapplications
AT pollarda studyingtheantibodyrepertoireaftervaccinationpracticalapplications
AT truckj studyingtheantibodyrepertoireaftervaccinationpracticalapplications
AT kellyd studyingtheantibodyrepertoireaftervaccinationpracticalapplications